aot2022v55i2

More documents

Recommendations

Info

Acta Oncologica Turcica 20226found in the first page. Every quotation used in the manuscript should be referenced.LETTER TO THE EDITORLetter to editor should be prepared as a manuscript which deeply evaluates the currentdevelopments both scientifically and socially, and which especially involves contributions orquestions for the articles submitted in the journal of Acta OncologicaTurcica. It should notexceed 1000 words and should have references section. No more than 5 references areallowed. It does not involve title or abstract sections.ArticleTypeUpper Word Limitof ManuscriptUpper WordLimit ofAbstractUpper Limit ofNumberofReferencesUpperlimitNumber ofAuthorsOriginalArticles3000 250 60 NoneReview 5000 250 60 5CaseReportLetter toEditor1200 250 15 None1000 No abstract 5 4AUTHOR CHECKLIST1. Cover Letter2. Title Page3. Main text - Manuscript (Abstract, in English and Turkish, should be included, buttables, graphics and figures should be excluded from the main text). For peer-reviewprocess, a blind manuscript should be prepared by the author and submitted to thesystem as a separate file.4. Figure captions (after references, at the end of the manuscript)5. Figures6. Tables, graphics7. Copyright Transfer Form8. Ethics committee approval (Location information of the Ethics Committee, date andthe number of the approval should be provided at the Material and Methods section ofthe main text)www.actaoncologicaturcica.comCopyright©Ankara Onkoloji Hastanesi
ACTA ONCOLOGICA TURCICA2022 Volume: 55 Issue: 2CONTENTSBRCA and non-BRCA Variants Detected by Next Generation Sequencing in Patientswith Hereditary Breast and/or Ovarian Cancer SyndromeKalıtsal Meme ve/veya Over Kanseri Sendromlu Olgularda Yeni Nesil Dizileme ileSaptanan BRCA ve non-BRCA VaryantlarHamide Betül Gerik-Çelebi, Hilmi BolatCan Preoperative Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio,and APRI Score Reliably Differentiate Uterine Sarcomas from Leiomyomas?Preoperatif Nötrofil Lenfosit Oranı, Platelet Lenfosit Oranı ve APRİ Skoru UterinSarkomları Myomlardan Ayırt Edebilir mi?Sezin Ertürk Aksakal, Hilal Korkmaz, Vakkas KorkmazClinicopathological Features and Survival Outcomes of 70 Tongue Squamous CellCarcinoma PatientsYetmiş Dil Skuamöz Hücre Karsinomu Hastasının Klinikopatolojik Özellikleri ve SağKalım SonuçlarıSelin Aktürk Esen, Denizcan Hastürk, Seda Kahraman, Yakup Ergun, Gökhan Uçar,Yusuf Acikgoz, Emre Hafızoğlu, Öznur Bal, Efnan Algın, Fahriye Tugba Köş,Mehmet Sendur, Doğan UncuComparison the Clinical Features of Newly Diagnosed Multiple Myeloma PatientsAccording to CD23 Expression StatusYeni Tanı Multipl Miyelom Hastalarının CD23 Ekspresyon Durumuna Göre KlinikÖzelliklerinin KarşılaştırılmasıUtku Iltar, Ozan Salim, Turgay Ulaş, Sibel Berker Karaüzüm, Çiğdem Aydin,Levent UndarNon-infectious Complications in Patients with Allogeneic Hematopoietic Stem CellTransplantation- Single Center Experience from Eastern AnatoliaDoğu Anadolu'dan Tek Merkez Deneyimi- Allojenik Hematopoietik Kök Hücre NakliYapılan Hastalarda Enfeksiyöz Olmayan KomplikasyonlarSevtap Karaman, Ahmet Sarıcı, Mehmet Ali Erkurt, Soykan Biçim, Emine Hidayet,Ahmet Kaya, İrfan Kuku, Saim Yologlu, Ilhami Berber, Emin Kaya, Mustafa ÖzgülPlatelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio in Patients withLocally Advanced Gastric CancersLokal İleri Mide Kanserli Hastalarda Trombosit Lenfosit Oranı ve Nötrofil LenfositOranıAhmet Karayiğit, Dursun Burak Özdemir, Hayrettin Dizen, Murat UlaşPage77-8485-9293-102103-108109-115116-127
Page 2 and 3: Acta Oncologica Turcica 2022EDITORI
Page 4 and 5: Acta Oncologica Turcica 20222should
Page 6 and 7: Acta Oncologica Turcica 20224KEYWOR
Page 10 and 11: Quality of Life Assessment with EOR
Page 12 and 13: Acta Oncologica Turcica 2022; 55: 7
Page 17: Acta Oncologica Turcica 2022; 55: 7
Page 58 and 59:
Acta Oncologica Turcica 2022; 55: 1
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
show all

aot2022v55i2

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?